Episode 9: Mark Mincy, Chief Commercial Officer at US-RX Care
Digital Health Heavyweights
Legislative Changes to Remove Incentives
Mark advocates removing class-of-trade incentives, prescriber payments, and rebates to select drugs by net cost.
In this episode of the Digital Health Heavyweights podcast, Norm Volsky interviews Mark Mincy, Chief Commercial Officer of USRX, to unpack the complex and often opaque world of pharmacy benefit management. They discuss fiduciary risks, conflicts of interest within traditional PBM models, and the structural incentives that drive up pharmacy costs for employers and employees. Mark shares his career journey in the pharmacy benefits space and explains why transparency, accountability, and independent fiduciary oversight are essential to meaningful reform. The conversation also explores specialty drug cost drivers, high-deductible health plans, legislative shifts, and how employers can take greater control of their pharmacy strategy without relying solely on legacy PBMs.
Takeaways
💊 Pharmacy benefit management is one of the most misunderstood drivers of healthcare costs.
⚖️ Fiduciary risk in pharmacy benefits is growing and requires employer attention.
🏦 Traditional PBM models often contain structural conflicts of interest.
🔍 Transparency is critical for controlling pharmacy spending.
📈 Specialty drug costs are a major contributor to rising employer healthcare expenses.
🏢 Employers can reclaim control by reevaluating vendor relationships.
📜 Legislative reform may reshape the future of pharmacy benefit management.
🔄 Alternative PBM models are gaining traction as cost containment solutions.
💡 Evaluating pharmacy vendors requires deeper scrutiny beyond surface-level pricing guarantees.
🧘♂️ Maintaining personal wellbeing is crucial in a high-pressure healthcare industry.
Chapters
00:00 Introduction to Pharmacy Benefit Management
03:02 Mark Mincy's Journey in Pharmacy Benefits
05:51 Understanding the Corruption in PBM Systems
08:40 The Role of Fiduciaries in Pharmacy Benefits
11:41 Challenges in the Current PBM Model
14:28 Legislative Recommendations for Pharmacy Benefits
17:15 Innovative Approaches at USRX Care
19:43 The Conflict of Interest in Pharmacy Benefits
22:01 Strategies for Managing Specialty Drug Costs
23:37 Taking Control of Pharmacy Benefits
25:50 The Impact of High-Deductible Health Plans
27:38 Future of Pharmacy Benefit Management
31:01 Evaluating Pharmacy Benefit Vendors
33:50 The Shift Towards Alternative PBMs
37:36 Navigating Change in Pharmacy Benefits
38:28 Maintaining Personal Well-being in a Stressful Industry
42:16 Outro
Follow, connect and subscribe:
LinkedIn: https://www.linkedin.com/company/digital-health-heavyweights-podcast
Youtube: https://youtube.com/@DigitalHealthHeavyweights
Instagram: https://www.instagram.com/digitalhealthheavyweights/
TikTok: https://www.tiktok.com/@heavyweightspodcast
The AI-powered Podcast Player
